Zhao Y - Search Results

1

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.

Zhao Y, Zhang E, Lv N, Ma L, Yao S, Yan M, Zi F, Deng G, Liu X, He J, Wu W, Cai Z, Yu R. Zhao Y, et al. Cell Physiol Biochem. 2018;48(2):785-800. doi: 10.1159/000491908. Epub 2018 Jul 20. Cell Physiol Biochem. 2018. PMID: 30032136 Free article.

2

Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack.

Bao H, Lu P, Li Y, Wang L, Li H, He D, Yang Y, Zhao Y, Yang L, Wang M, Yi Q, Cai Z. Bao H, et al. Among authors: zhao y. Cancer Biol Ther. 2011 Jan 1;11(1):58-67. doi: 10.4161/cbt.11.1.13878. Cancer Biol Ther. 2011. PMID: 21248470 Free article.

3

[TLR4 and organ transplant rejection].

Zhao Y, Cai Z. Zhao Y, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Sep;40(5):495-500. doi: 10.3785/j.issn.1008-9292.2011.05.006. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21984151 Review. Chinese.

4

Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.

Wang L, Zhao Y, Qian J, Sun L, Lu Y, Li H, Li Y, Yang J, Cai Z, Yi Q. Wang L, et al. Among authors: zhao y. Cancer. 2013 Feb 15;119(4):782-91. doi: 10.1002/cncr.27792. Epub 2012 Aug 22. Cancer. 2013. PMID: 22915070 Free PMC article.

5

TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Zhao Y, Liu Q, Yang L, He D, Wang L, Tian J, Li Y, Zi F, Bao H, Yang Y, Zheng Y, Shi J, Xue X, Cai Z. Zhao Y, et al. Cell Mol Immunol. 2013 Mar;10(2):165-75. doi: 10.1038/cmi.2012.58. Epub 2012 Dec 24. Cell Mol Immunol. 2013. PMID: 23262974 Free PMC article.

6

Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells.

Qian X, He J, Zhao Y, Lin M. Qian X, et al. Among authors: zhao y. Am J Ther. 2016 May-Jun;23(3):e680-9. doi: 10.1097/01.mjt.0000433950.01406.b3. Am J Ther. 2016. PMID: 24141198

7

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.

He J, Yang L, Han X, Zheng G, Zheng W, Wei G, Wu W, Ye X, Shi J, Xie W, Li L, Zhang J, Huang W, Zhao Y, Huang H, Zhang X, Fu J, Cai Z. He J, et al. Among authors: zhao y. PLoS One. 2014 Jun 11;9(6):e99174. doi: 10.1371/journal.pone.0099174. eCollection 2014. PLoS One. 2014. PMID: 24918626 Free PMC article.

8

Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.

Zi FM, He JS, Li Y, Wu C, Wu WJ, Yang Y, Wang LJ, He DH, Yang L, Zhao Y, Zheng GF, Han XY, Huang H, Yi Q, Cai Z. Zi FM, et al. Among authors: zhao y. Cancer Biol Ther. 2014 Oct;15(10):1413-22. doi: 10.4161/cbt.29924. Epub 2014 Jul 21. Cancer Biol Ther. 2014. PMID: 25046247 Free PMC article.

9

Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.

Zi FM, He JS, Li Y, Wu C, Yang L, Yang Y, Wang LJ, He DH, Zhao Y, Wu WJ, Zheng GF, Han XY, Huang H, Yi Q, Cai Z. Zi FM, et al. Among authors: zhao y. Cancer Lett. 2015 Jan 28;356(2 Pt B):443-53. doi: 10.1016/j.canlet.2014.09.050. Epub 2014 Oct 8. Cancer Lett. 2015. PMID: 25305450

10

Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.

Wu W, Yang Y, Deng G, Ma L, Wei G, Zheng G, Han X, He D, Zhao Y, He J, Cai Z, Yu R. Wu W, et al. Among authors: zhao y. Mol Carcinog. 2017 Oct;56(10):2190-2199. doi: 10.1002/mc.22672. Epub 2017 May 15. Mol Carcinog. 2017. PMID: 28467689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,022 results

Search Page

Filters